Ascentage Pharma Group International (OTCMKTS:ASPHF – Get Free Report) was the recipient of a large growth in short interest in June. As of June 30th, there was short interest totaling 541,300 shares, a growth of 213.3% from the June 15th total of 172,800 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.
Ascentage Pharma Group International Price Performance
Shares of ASPHF stock opened at $4.53 on Monday. The stock has a fifty day moving average price of $5.38 and a 200 day moving average price of $7.39. Ascentage Pharma Group International has a 1 year low of $4.53 and a 1 year high of $5.05.
About Ascentage Pharma Group International
Ascentage Pharma Group International (OTCMKTS:ASPHF) is a clinical-stage biopharmaceutical company headquartered in Beijing, China, with a strategic presence in the United States. The company focuses on the discovery and development of targeted small-molecule therapies that modulate programmed cell death, leveraging a deep understanding of the Bcl-2 family of proteins.
Ascentage’s core activities center on the research and development of apoptosis regulators, including both Bcl-2 selective and dual Bcl-2/Bcl-xL inhibitors.
Further Reading
- Five stocks we like better than Ascentage Pharma Group International
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
